Cargando…

Rapid Regulatory T-Cell Response Prevents Cytokine Storm in CD28 Superagonist Treated Mice

Superagonistic CD28-specific monoclonal antibodies (CD28SA) are highly effective activators of regulatory T-cells (Treg cells) in rats, but a first-in-man trial of the human CD28SA TGN1412 resulted in an unexpected cytokine release syndrome. Using a novel mouse anti-mouse CD28SA, we re-investigate t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gogishvili, Tea, Langenhorst, Daniela, Lühder, Fred, Elias, Fernando, Elflein, Karin, Dennehy, Kevin M., Gold, Ralf, Hünig, Thomas
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2009
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2645706/ https://www.ncbi.nlm.nih.gov/pubmed/19247496 http://dx.doi.org/10.1371/journal.pone.0004643

Ejemplares similares

CD28 and IL-4: two heavyweights controlling the balance between immunity and inflammation
por: Hünig, Thomas, et al.
Publicado: (2010)

Topological Requirements and Signaling Properties of T Cell–activating, Anti-CD28 Antibody Superagonists
por: Lühder, Fred, et al.
Publicado: (2003)

Self-Recognition Sensitizes Mouse and Human Regulatory T Cells to Low-Dose CD28 Superagonist Stimulation
por: Langenhorst, Daniela, et al.
Publicado: (2018)

Selective targeting of regulatory T cells with CD28 superagonists allows effective therapy of experimental autoimmune encephalomyelitis
por: Beyersdorf, Niklas, et al.
Publicado: (2005)

CD28 Costimulation of T Helper 1 Cells Enhances Cytokine Release In Vivo
por: Langenhorst, Daniela, et al.
Publicado: (2018)

Sequential Induction of Effector Function, Tissue Migration and Cell Death during Polyclonal Activation of Mouse Regulatory T-Cells
por: Langenhorst, Daniela, et al.
Publicado: (2012)

Expansion of regulatory T cells by CD28 superagonistic antibodies attenuates neurodegeneration in A53T-α-synuclein Parkinson’s disease mice
por: Badr, Mohammad, et al.
Publicado: (2022)

CD28 Superagonist Shock and Blockage of Motogenic T Cell Cascade
por: Sundqvist, Karl-Gösta
Publicado: (2021)

Protection of Mice from Acute Graft-versus-Host Disease Requires CD28 Co-stimulation on Donor CD4(+) Foxp3(+) Regulatory T Cells
por: Uri, Anna, et al.
Publicado: (2017)

Signaling Signatures and Functional Properties of Anti-Human CD28 Superagonistic Antibodies
por: Waibler, Zoe, et al.
Publicado: (2008)

Combinations of anti-GITR antibody and CD28 superagonist induce permanent allograft acceptance by generating type 1 regulatory T cells
por: Que, Weitao, et al.
Publicado: (2022)

Anti-CD28 Antibody-Initiated Cytokine Storm in Canines
por: Rosinski, Steven L., et al.
Publicado: (2015)

CD28 superagonist-mediated boost of regulatory T cells increases thrombo-inflammation and ischemic neurodegeneration during the acute phase of experimental stroke
por: Schuhmann, Michael K, et al.
Publicado: (2015)

Superagonistic CD28 protects against renal ischemia injury induced fibrosis through a regulatory T-cell expansion dependent mechanism
por: Liang, Yiran, et al.
Publicado: (2019)

CD28 Superagonistic Activation of T Cells Induces a Tumor Cell-Like Metabolic Program
por: Thaventhiran, Thilipan, et al.
Publicado: (2019)

Inducible Deletion of CD28 Prior to Secondary Nippostrongylus brasiliensis Infection Impairs Worm Expulsion and Recall of Protective Memory CD4(+) T Cell Responses
por: Ndlovu, Hlumani, et al.
Publicado: (2014)

Revisiting CD28 Superagonist TGN1412 as Potential Therapeutic for Pediatric B Cell Leukemia: A Review
por: Brown, Katelyn E.
Publicado: (2018)

Inhibition of ZAP-70 Kinase Activity via an Analog-sensitive Allele Blocks T Cell Receptor and CD28 Superagonist Signaling
por: Levin, Susan E., et al.
Publicado: (2008)

Failure to upregulate cell surface PD-1 is associated with dysregulated stimulation of T cells by TGN1412-like CD28 superagonist
por: Thaventhiran, Thilipan, et al.
Publicado: (2014)

Are there superagonists for calcium-activated potassium channels?
por: Brown, Brandon M., et al.
Publicado: (2017)

Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties
por: Elsayed, Abdullah, et al.
Publicado: (2023)

CD28 co-stimulation in T-cell homeostasis: a recent perspective
por: Beyersdorf, Niklas, et al.
Publicado: (2015)

Cytokine Storm
por: Fajgenbaum, David C., et al.
Publicado: (2020)

Immune reconstitution and clinical recovery following anti-CD28 antibody (TGN1412)-induced cytokine storm
por: Panoskaltsis, Nicki, et al.
Publicado: (2020)

CD28-signaling can be partially compensated in CD28-knockout mice but is essential for virus elimination in a murine model of multiple sclerosis
por: Hülskötter, Kirsten, et al.
Publicado: (2023)

Mechanisms involved in IL-15 superagonist enhancement of anti-PD-L1 therapy
por: Knudson, Karin M., et al.
Publicado: (2019)

Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor
por: Thirunarayanan, Nanthakumar, et al.
Publicado: (2012)

New Roles for Vitamin D Superagonists: From COVID to Cancer
por: Easty, David J., et al.
Publicado: (2021)

Rapid Radiological Worsening and Cytokine Storm Syndrome in COVID-19 Pneumonia
por: Ruch, Yvon, et al.
Publicado: (2020)

Gpr174-deficient regulatory T cells decrease cytokine storm in septic mice
por: Qiu, Dongze, et al.
Publicado: (2019)

Mu-opioid receptor selective superagonists produce prolonged respiratory depression
por: Malcolm, Nicholas J., et al.
Publicado: (2023)

CALM BEFORE THE STORM: COVID-19 AND CYTOKINE STORM SYNDROME
por: Chahal, Japjot, et al.
Publicado: (2020)

Dynamics of a Cytokine Storm
por: Yiu, Hao Hong, et al.
Publicado: (2012)

Agents to reduce cytokine storm
por: Gerlach, Herwig
Publicado: (2016)

Leptospirosis Pathophysiology: Into the Storm of Cytokines
por: Cagliero, Julie, et al.
Publicado: (2018)

Cytokine storms in infectious diseases
por: Teijaro, John R.
Publicado: (2017)

Are all cytokine storms the same?
por: Panoskaltsis, Nicki
Publicado: (2021)

The Roles of Neutrophils in Cytokine Storms
por: Chan, Lily, et al.
Publicado: (2021)

Galectin-8, cytokines, and the storm
por: Zick, Yehiel
Publicado: (2022)

Functional and mechanistic advantage of the use of a bifunctional anti-PD-L1/IL-15 superagonist
por: Knudson, Karin M, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_20248rpsldbtncomo6n7s6jrs9